4//SEC Filing
Harmon Cyrus 4
Accession 0001831410-25-000004
CIK 0001750284other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 9:30 PM ET
Size
10.8 KB
Accession
0001831410-25-000004
Insider Transaction Report
Form 4
Harmon Cyrus
Director
Transactions
- Sale
Common Stock
2025-09-18$8.32/sh−3,086$25,676→ 117,028 total(indirect: See Footnote) - Sale
Common Stock
2025-09-16$8.04/sh−10,000$80,400→ 754,140 total - Sale
Common Stock
2025-09-18$8.33/sh−10,000$83,300→ 744,140 total - Sale
Common Stock
2025-09-16$8.08/sh−1,914$15,465→ 120,114 total(indirect: See Footnote)
Footnotes (5)
- [F1]The weighted average sale price for the transaction reported was $8.04, and the range of prices was between $8.02 and $8.09. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F2]The weighted average sale price for the transaction reported was $8.33, and the range of prices was between $8.28 and $8.37. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The weighted average sale price for the transaction reported was $8.08, and the range of prices was between $8.04 and $8.08. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F4]The shares are held by the Harmon Family Investors LLC, of which the Reporting Person is the manager.
- [F5]The weighted average sale price for the transaction reported was $8.32, and the range of prices was between $8.29 and $8.33. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
Documents
Issuer
Olema Pharmaceuticals, Inc.
CIK 0001750284
Entity typeother
Related Parties
1- filerCIK 0001831410
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 9:30 PM ET
- Size
- 10.8 KB